resveratrol has been researched along with Arteriosclerosis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Chen, J; Cui, Y; Zeng, G; Zhang, G | 1 |
| Choi, MS; Jeon, SM; Lee, SA | 1 |
| Chen, Z; Han, HP; He, JP; Xie, HC | 1 |
| Bergante, S; D'Orazio, N; Gammone, MA; Pluchinotta, FR; Riccioni, G; Tettamanti, G | 1 |
| Austin, C; Azzawi, M; Degens, H; Diaz, M; Vanhees, L | 1 |
| Das, DK; Gesztelyi, R; Juhasz, A; Juhasz, B; Juhaz, B; Kertesz, A; Varga, B | 1 |
| Ancora, MA; Carluccio, MA; De Caterina, R; Distante, A; Massaro, M; Scoditti, E; Siculella, L; Storelli, C; Visioli, F | 1 |
| Chen, LN; Tang, YH; Zang, WJ | 1 |
| Fukao, H; Fukunaga, C; Hashimoto, M; Ijiri, Y; Kawai, Y; Miura, M; Oiwa, K; Suwa, M; Yamamoto, J; Yamashita, T | 1 |
| Szmitko, PE; Verma, S | 1 |
| Auger, C; Besançon, P; Bornet, A; Caporiccio, B; Cristol, JP; Gérain, P; Lequeux, N; Rouanet, JM; Serisier, S; Teissedre, PL | 1 |
| Delmas, D; Jannin, B; Latruffe, N | 1 |
| Cruzado, M; Miatello, R; Renna, N; Risler, N; Vázquez, M; Zumino, AP | 1 |
| Lecour, S; Opie, LH | 1 |
| Diamandis, EP; Goldberg, DM; Hahn, S; Pace-Asciak, CR; Soleas, G | 1 |
| Beitz, DC; Engen, RL; Knight, TJ; Lewis, DS; Wilson, T | 1 |
| Frémont, L | 1 |
| Diamandis, EP; Goldberg, DM; Soleas, GJ | 1 |
| Cao, K; Huang, Y; Wang, Z; Wu, JM; Xu, Y; Zou, J | 1 |
7 review(s) available for resveratrol and Arteriosclerosis
| Article | Year |
|---|---|
Resveratrol and anti-atherogenic effects.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Humans; Resveratrol; Stilbenes | 2015 |
The effects of resveratrol on aging vessels.
Topics: Aging; Animals; Antioxidants; Arteriosclerosis; Autophagy; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Oxidative Stress; Resveratrol; Stilbenes | 2016 |
[Progress in cardiovascular protective effects of resveratrol].
Topics: Animals; Antioxidants; Arteriosclerosis; Cardiovascular Agents; Humans; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Vasodilator Agents | 2003 |
Resveratrol: preventing properties against vascular alterations and ageing.
Topics: Aging; Arteriosclerosis; Cardiovascular Diseases; Foam Cells; Health Promotion; Humans; Lipoproteins; Macrophages; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Oxidative Stress; Platelet Aggregation; Resveratrol; Stilbenes; Vasodilation | 2005 |
The red wine hypothesis: from concepts to protective signalling molecules.
Topics: Alcohol Drinking; Animals; Arteriosclerosis; Coronary Disease; Female; Flavonoids; Humans; Hypertension; Male; Mice; Phenols; Platelet Aggregation; Platelet Aggregation Inhibitors; Polyphenols; Rats; Resveratrol; Risk Factors; Stilbenes; Wine | 2007 |
Biological effects of resveratrol.
Topics: Anticarcinogenic Agents; Antioxidants; Arteriosclerosis; Humans; Resveratrol; Rosales; Stilbenes; Wine | 2000 |
The world of resveratrol.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Arteriosclerosis; Biological Availability; Cell Division; Gene Transfer, Horizontal; Humans; Inflammation; Intestinal Absorption; Neoplasms; Resveratrol; Stilbenes; Vitis | 2001 |
12 other study(ies) available for resveratrol and Arteriosclerosis
| Article | Year |
|---|---|
Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Cell Line; DNA, Complementary; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; L-Lactate Dehydrogenase; Lysophosphatidylcholines; Models, Cardiovascular; Myeloid Differentiation Factor 88; NF-kappa B; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2018 |
Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice.
Topics: Animals; Anti-Obesity Agents; Anticholesteremic Agents; Aorta; Apolipoproteins E; Arteriosclerosis; Diet, Atherogenic; Humans; Lovastatin; Male; Mice; Mice, Knockout; Obesity; Protective Agents; Resveratrol; Stilbenes | 2014 |
A study on the effect of resveratrol on lipid metabolism in hyperlipidemic mice.
Topics: Animals; Arteriosclerosis; Cholesterol; Dose-Response Relationship, Drug; Fallopia japonica; Hyperlipidemias; Lipid Metabolism; Male; Mice; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes; Triglycerides | 2014 |
Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Biomarkers; Cholesterol; Disease Models, Animal; Down-Regulation; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Resveratrol; Stilbenes; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals.
Topics: Animals; Antioxidants; Arteriosclerosis; Cattle; Cell Adhesion; Cells, Cultured; Diet; Endothelium, Vascular; Flavonoids; Gene Expression Regulation; Humans; Iridoid Glucosides; Iridoids; NF-kappa B; Olive Oil; Phenols; Phenylethyl Alcohol; Plant Oils; Polyphenols; Pyrans; Resveratrol; RNA, Messenger; Stilbenes; Transcription Factor AP-1; Transcription, Genetic; U937 Cells; Vascular Cell Adhesion Molecule-1; Wine | 2003 |
Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice.
Topics: Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Carotid Artery Thrombosis; Cholesterol; Diet, Atherogenic; Dietary Fats; Drug Evaluation, Preclinical; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation; Radiation Injuries, Experimental; Receptors, LDL; Resveratrol; Stilbenes; Thrombophilia; Triglycerides | 2004 |
Cardiology patient pages. Red wine and your heart.
Topics: Alcohol Drinking; Animals; Antioxidants; Arteriosclerosis; Cohort Studies; Cricetinae; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Flavonoids; Follow-Up Studies; Gene Expression Regulation; Humans; Male; Middle Aged; Myocardial Infarction; Phenols; Phytotherapy; Polyphenols; Rabbits; Resveratrol; Risk; Stilbenes; Stroke; Wine | 2005 |
Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Catechin; Cricetinae; Disease Models, Animal; Hypercholesterolemia; Male; Mesocricetus; Quercetin; Resveratrol; Stilbenes; Wine | 2005 |
Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats.
Topics: Administration, Oral; Animal Feed; Animals; Antioxidants; Arteriosclerosis; Biomarkers; Blood Pressure; Follow-Up Studies; Fructose; Heart Ventricles; Hypertension; Insulin Resistance; Lipid Peroxidation; Male; Mesenteric Arteries; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Resveratrol; Risk Factors; Spectrophotometry; Stilbenes; Sweetening Agents; Thiobarbituric Acid Reactive Substances; Time Factors | 2005 |
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease.
Topics: Arteriosclerosis; Coronary Disease; Eicosanoids; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Quercetin; Resveratrol; Stilbenes; Wine | 1995 |
Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Disease Models, Animal; Kidney; Lipoproteins; Liver; Male; Platelet Aggregation Inhibitors; Rabbits; Resveratrol; Stilbenes | 1996 |
Effect of resveratrol on platelet aggregation in vivo and in vitro.
Topics: Animals; Arteriosclerosis; Cholesterol, LDL; Humans; Lipids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Resveratrol; Stilbenes | 2002 |